A novel BRD4 degrader, ARV-825, attenuates lung fibrosis through senolysis and antifibrotic effect-Reference-Cited by-同舟云学术

A novel BRD4 degrader, ARV-825, attenuates lung fibrosis through senolysis and antifibrotic effect

Published:2023-11 Issue:6 Volume:61 Page:781-792
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Sato Seidai^ORCID,Koyama Kazuya,Ogawa Hirohisa,Murakami Kojin,Imakura Takeshi,Yamashita Yuya,Kagawa Kozo,Kawano Hiroshi^ORCID,Hara Eiji,Nishioka Yasuhiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference43 articles.

1. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada;Hopkins;Eur Respir J,2016

2. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review;Hutchinson;Eur Respir J,2015

3. Idiopathic pulmonary fibrosis;King;Lancet,2011

4. Cellular senescence in ageing: from mechanisms to therapeutic opportunities;Di Micco;Nat Rev Mol Cell Biol,2021

5. Cellular senescence in aging primates;Herbig;Science,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRD4: an effective target for organ fibrosis;Biomarker Research;2024-08-30

2. Targeting BRD4 with PROTAC degrader ameliorates LPS-induced acute lung injury by inhibiting M1 alveolar macrophage polarization;International Immunopharmacology;2024-05

3. Injectable hydrogel-based tumor vaccine with fibrotic tumor immune microenvironment remodeling to prevent breast cancer postoperative recurrence and metastases;Chinese Chemical Letters;2024-05

4. Current senolytics: Mode of action, efficacy and limitations, and their future;Mechanisms of Ageing and Development;2024-02